Figures & data
Figure 1. Enrollment scheme and patient status. CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.
![Figure 1. Enrollment scheme and patient status. CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.](/cms/asset/5a2a4977-5877-4e5e-b394-901c40f16e21/irnf_a_731997_f0001_b.gif)
Figure 2. The effect of MDC duration on the rate of renal progression in stage 5 CKD patients.
The horizontal dotted line corresponds to the level of kidney function at the initiation of dialysis (eGFR = 5 mL/min/1.73 m2). The declines in kidney function are illustrated as diagonal lines.
![Figure 2. The effect of MDC duration on the rate of renal progression in stage 5 CKD patients.The horizontal dotted line corresponds to the level of kidney function at the initiation of dialysis (eGFR = 5 mL/min/1.73 m2). The declines in kidney function are illustrated as diagonal lines.](/cms/asset/2fa5ef5d-e0a5-489e-8bb1-1d3287892409/irnf_a_731997_f0002_b.jpg)
Figure 3. Delivery of annual medical cost savings.
Per capita medical cost savings resulting from longer (>1 year) MDC was estimated for the cases with delayed onset of hemodialysis.
Annual cost savings = delay time (months) × hemodialysis sessions per month × reimbursement ÷ 12 = [(83.33 − 7.57) × 13 × 4100 ÷ 12] = NTD 336,500.66 compared with the cost of care incurred by the Taiwan Society of Nephrology (1 USD = 29.7 NTD).
![Figure 3. Delivery of annual medical cost savings.Per capita medical cost savings resulting from longer (>1 year) MDC was estimated for the cases with delayed onset of hemodialysis.Annual cost savings = delay time (months) × hemodialysis sessions per month × reimbursement ÷ 12 = [(83.33 − 7.57) × 13 × 4100 ÷ 12] = NTD 336,500.66 compared with the cost of care incurred by the Taiwan Society of Nephrology (1 USD = 29.7 NTD).](/cms/asset/5a993d68-304f-4db9-a953-122a468436e9/irnf_a_731997_f0003_b.jpg)
Figure 4. The effect of MDC on the rate of renal progression in stage 5 CKD patients with or without DM.The diabetic group had a steeper rate of decline in mean eGFR and a shorter follow-up period than the nondiabetic group.
![Figure 4. The effect of MDC on the rate of renal progression in stage 5 CKD patients with or without DM.The diabetic group had a steeper rate of decline in mean eGFR and a shorter follow-up period than the nondiabetic group.](/cms/asset/e0155f05-bc41-434d-851d-3b0ec539b0bd/irnf_a_731997_f0004_b.jpg)
Table 1. Summary of demographics at incidental dialysis initiation in CKD noneducational intervention and CKD educational intervention groups.
Table 2. Unadjusted and adjusted OR and 95% CI of high medical costsFootnotea associated with stage 5 CKD patients without the MDC program.
Table 3. The effect of MDC duration on the laboratory data and the rate of renal disease progression in stage 5 CKD patients between 1 January 2005 and 31 May 2008.
Table 4. The effect of MDC on the rate of renal progression in stage 5 CKD patients with DM and without DM between 1 January 2005 and 31 May 2008.